Homologous Recombination Repair

Homologous Recombination Repair (HRR) is the DNA repair pathway that resolves double-strand breaks and other complex DNA lesions with high fidelity by using an intact, sequence-identical or nearly identical DNA template — typically the sister chromatid generated during replication — to accurately restore the original sequence at the site of damage, distinguishing it from the more error-prone repair pathways available for double-strand break resolution and making it the preferred, most accurate repair route whenever a suitable template is available.

Why a Template-Based Approach Matters for Double-Strand Breaks

The Distinct Challenge of Double-Strand Breaks

Unlike the single-strand lesions addressed by base excision repair, nucleotide excision repair, and mismatch repair — all of which can use the opposite, intact strand of the same DNA molecule as a reference — a double-strand break severs both strands simultaneously, leaving no intact local template within the same DNA molecule to guide accurate repair, necessitating an entirely different strategy that instead borrows sequence information from elsewhere in the genome.

The Sister Chromatid as the Preferred Template

Because HRR requires a template that is genuinely identical or near-identical in sequence to the region surrounding the break, and because the sister chromatid produced during S phase provides exactly this, HRR is intrinsically restricted to the S and G2 phases of the cell cycle when a sister chromatid is available, distinguishing it cell-cycle-wise from non-homologous end joining, which can operate throughout the cell cycle without this requirement.

The Core HRR Mechanism

End Resection

HRR begins with resection of the DNA ends flanking the break, generating long 3' single-stranded DNA overhangs — this resection step, carried out by the MRN complex together with additional resection factors, is a committing step that channels the break toward the HRR pathway rather than toward non-homologous end joining, which instead requires largely unresected ends.

RAD51-Mediated Strand Invasion

The resected single-stranded DNA is coated by RAD51, forming a nucleoprotein filament that searches for and invades a homologous sequence — typically the sister chromatid — displacing one strand of the template duplex to form a D-loop structure, physically pairing the damaged DNA's single strand with the matching sequence of the intact template.

DNA Synthesis Using the Template

DNA polymerase extends the invading 3' end, synthesizing new DNA using the intact template strand as reference, accurately copying the correct sequence across the region that had been lost or damaged at the break site — this templated synthesis is the direct source of HRR's high fidelity relative to end-joining-based repair pathways that lack any equivalent templated correction step.

Resolution of Recombination Intermediates

Following DNA synthesis, the resulting recombination intermediates (Holliday junctions or related structures) are resolved by dedicated resolvase or dissolvase enzymes, ultimately restoring two intact, correctly sequenced DNA duplexes and completing the repair with the original sequence information faithfully preserved.

Key Regulatory and Structural Components

BRCA1 and BRCA2

BRCA1 functions early in the pathway, promoting the decision to pursue end resection and thereby favoring HRR over non-homologous end joining, while BRCA2 acts later, directly loading RAD51 onto the resected single-stranded DNA to enable strand invasion — the central, well-established role of both proteins in HRR is why their inherited loss-of-function mutations confer such substantially elevated hereditary cancer risk, particularly for breast and ovarian cancer.

The 53BP1-BRCA1 Pathway Choice Axis

The decision between HRR and non-homologous end joining at a given double-strand break is substantially governed by a regulatory competition between BRCA1 (promoting resection and HRR) and 53BP1 (restraining resection and favoring end joining), with cell cycle phase, chromatin context, and additional regulatory factors together determining which pathway ultimately processes a given break.

Consequences of HRR Deficiency

Reliance on Error-Prone Alternative Repair

Cells deficient in HRR, whether through BRCA1/BRCA2 mutation or loss of other core pathway components, are forced to rely more heavily on non-homologous end joining and other error-prone alternative repair routes for resolving double-strand breaks, producing the characteristic elevated burden of structural genomic rearrangement — including specific tandem duplication and deletion signatures — used clinically as a genomic marker of HRR deficiency.

Synthetic Lethality With PARP Inhibition

HRR-deficient cells show pronounced sensitivity to PARP inhibitors, a relationship termed synthetic lethality — PARP inhibition impairs the resolution of single-strand breaks and stalled replication forks that would normally be resolved efficiently by HRR-mediated repair in a proficient cell, but in an HRR-deficient cell, these unresolved lesions accumulate into double-strand breaks the cell cannot accurately repair, driving it toward death — representing one of the most clinically significant translations of basic DNA repair biology into targeted cancer therapy developed to date.

HRR's Role Beyond Cancer Predisposition

Genome Stability Maintenance Broadly

Beyond its well-known relevance to hereditary breast and ovarian cancer risk, HRR plays a continuous, essential role in maintaining genome stability during normal cell division by accurately resolving the double-strand breaks that arise from replication fork collapse and other routine sources of DNA damage throughout the cell cycle in any actively dividing cell, not solely in cells carrying inherited pathway mutations.

Interaction With Broader Genome Instability Mechanisms

HRR proficiency directly influences the structural genome instability discussed elsewhere in this topic area — a cell's capacity to accurately resolve double-strand breaks via HRR, rather than defaulting to error-prone alternative pathways, substantially determines whether a given break resolves cleanly or contributes further structural rearrangement to the genome.

Practical Significance

Homologous Recombination Repair provides the highest-fidelity route available for resolving DNA double-strand breaks, using the sister chromatid as a template through a mechanism of end resection, RAD51-mediated strand invasion, templated synthesis, and recombination intermediate resolution, restricted to the S and G2 phases when that template is available. Its central mediators, BRCA1 and BRCA2, connect this fundamental repair mechanism directly to hereditary cancer risk, while HRR deficiency's synthetic lethal relationship with PARP inhibition represents one of the clearest and most clinically impactful examples of exploiting a specific DNA repair pathway defect for targeted cancer treatment.